ACRX · Categories · Form 4

ACRX - SEC Form 4 insider transactions

AcelRx Pharmaceuticals Inc. (ACRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ACRX

• 840d
  Dasu Badri N covered exercise/tax liability with 1,618 shares, decreasing direct ownership by 9% to 17,153 units (SEC Form 4)

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 840d
  Palmer Pamela P covered exercise/tax liability with 1,602 shares, decreasing direct ownership by 4% to 35,344 units (SEC Form 4)

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 840d
  Asadorian Raffi covered exercise/tax liability with 1,790 shares, decreasing direct ownership by 8% to 20,291 units (SEC Form 4)

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 840d
  Angotti Vincent J. covered exercise/tax liability with 7,043 shares, decreasing direct ownership by 7% to 94,762 units (SEC Form 4)

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 861d
  SEC Form 4 filed by Nantahala Capital Management, Llc

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 862d
  Jain Abhinav was granted 871 shares (SEC Form 4)

  4 - TALPHERA, INC. (0001427925) (Issuer)
• 903d
  Hoffman Stephen J was granted 581 shares, increasing direct ownership by 32% to 2,418 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Afable Richard was granted 581 shares, increasing direct ownership by 31% to 2,468 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Wan Mark A was granted 581 shares, increasing direct ownership by 32% to 2,418 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Bozilenko Marina was granted 581 shares, increasing direct ownership by 29% to 2,606 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Broadfoot Jill Marie was granted 581 shares, increasing direct ownership by 38% to 2,106 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Rosen Howard B was granted 581 shares, increasing direct ownership by 12% to 5,293 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 903d
  Adams Adrian was granted 581 shares, increasing direct ownership by 5% to 11,168 units (SEC Form 4)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 996d
  SEC Form 4: Angotti Vincent J. bought $7,950 worth of shares (10,000 units at $0.80), increasing direct ownership by 12% to 91,805 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1013d
  SEC Form 4: Palmer Pamela P sold $19,236 worth of shares (16,956 units at $1.13), decreasing direct ownership by 36% to 30,753 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1205d
  SEC Form 4: Angotti Vincent J. was granted 19,500 shares and covered exercise/tax liability with 3,321 shares, increasing direct ownership by 33% to 65,539 units to satisfy withholding tax

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1211d
  SEC Form 4: Dasu Badri N covered exercise/tax liability with 458 shares, decreasing direct ownership by 3% to 15,070 units (withholding tax)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1211d
  SEC Form 4: Asadorian Raffi covered exercise/tax liability with 617 shares, decreasing direct ownership by 3% to 17,589 units to cover withholding tax

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1211d
  SEC Form 4: Palmer Pamela P covered exercise/tax liability with 681 shares, decreasing direct ownership by 2% to 38,777 units to satisfy tax liability

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1211d
  SEC Form 4: Angotti Vincent J. covered exercise/tax liability with 1,982 shares, decreasing direct ownership by 4% to 49,360 units to satisfy withholding tax

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Broadfoot Jill Marie was granted 15,500 shares, increasing direct ownership by 103% to 30,500 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Bozilenko Marina was granted 15,500 shares, increasing direct ownership by 62% to 40,500 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Afable Richard was granted 15,500 shares, increasing direct ownership by 70% to 37,750 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Adams Adrian was granted 15,500 shares, increasing direct ownership by 8% to 211,750 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Hoffman Stephen J was granted 15,500 shares, increasing direct ownership by 73% to 36,750 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Rosen Howard B was granted 15,500 shares, increasing direct ownership by 20% to 94,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1419d
  SEC Form 4: Wan Mark A was granted 15,500 shares, increasing direct ownership by 73% to 36,750 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1456d
  SEC Form 4: Angotti Vincent J. bought $10,333 worth of shares (46,400 units at $0.22), increasing direct ownership by 5% to 1,016,919 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1552d
  SEC Form 4: Palmer Pamela P covered exercise/tax liability with 7,923 shares, decreasing direct ownership by 1% to 779,261 units (withholding obligation)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1552d
  SEC Form 4: Dasu Badri N covered exercise/tax liability with 5,612 shares, decreasing direct ownership by 2% to 300,595 units (for tax liability)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1552d
  SEC Form 4: Asadorian Raffi covered exercise/tax liability with 7,923 shares, decreasing direct ownership by 2% to 364,205 units (withholding tax)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1552d
  SEC Form 4: Angotti Vincent J. covered exercise/tax liability with 23,051 shares, decreasing direct ownership by 2% to 970,519 units to satisfy tax liability

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1570d
  SEC Form 4: Dasu Badri N was granted 97,500 shares and covered exercise/tax liability with 5,615 shares, increasing direct ownership by 45% to 296,207 units (for tax liability)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1570d
  SEC Form 4: Palmer Pamela P was granted 122,500 shares and covered exercise/tax liability with 7,927 shares, increasing direct ownership by 17% to 777,184 units to satisfy tax liability

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1576d
  SEC Form 4: Palmer Pamela P covered exercise/tax liability with 9,391 shares, decreasing direct ownership by 1% to 662,611 units to cover withholding tax

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1576d
  SEC Form 4: Dasu Badri N covered exercise/tax liability with 6,830 shares, decreasing direct ownership by 3% to 204,322 units (withholding tax)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1576d
  SEC Form 4: Asadorian Raffi covered exercise/tax liability with 9,391 shares, decreasing direct ownership by 4% to 258,515 units to cover withholding tax

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1576d
  SEC Form 4: Angotti Vincent J. covered exercise/tax liability with 27,318 shares, decreasing direct ownership by 4% to 616,628 units (for withholding tax)

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1653d
  SEC Form 4: Broadfoot Jill Marie was granted 15,000 shares

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: WAN MARK A was granted 10,000 units of Common Stock, increasing direct ownership by 89% to 21,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: ADAMS ADRIAN was granted 10,000 units of Common Stock, increasing direct ownership by 5% to 196,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: Rosen Howard B was granted 10,000 units of Common Stock, increasing direct ownership by 15% to 78,750 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: Afable Richard was granted 10,000 units of Common Stock, increasing direct ownership by 82% to 22,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: Bozilenko Marina was granted 10,000 units of Common Stock, increasing direct ownership by 67% to 25,000 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: HOFFMAN STEPHEN J was granted 10,000 units of Common Stock, increasing direct ownership by 89% to 21,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1812d
  SEC Form 4: EDWARDS MARK G was granted 10,000 units of Common Stock, increasing direct ownership by 4% to 261,250 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1890d
  SEC Form 4: Marina Bozilenko was granted 15,000 units of Common Stock

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1916d
  SEC Form 4: P Pamela Palmer was granted 68,750 units of Common Stock, increasing direct ownership by 11% to 666,621 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1916d
  SEC Form 4: N Badri Dasu was granted 50,000 units of Common Stock, increasing direct ownership by 32% to 204,757 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1916d
  SEC Form 4: Raffi Asadorian was granted 68,750 units of Common Stock, increasing direct ownership by 36% to 260,597 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1916d
  SEC Form 4: J. Vincent Angotti was granted 200,000 units of Common Stock, increasing direct ownership by 46% to 636,980 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1937d
  SEC Form 4: Raffi Asadorian disposed of $23,733 worth of Common Stock (9,024 units at $2.63), decreasing ownership by 5% to 183,299 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1937d
  SEC Form 4: N Badri Dasu disposed of $17,818 worth of Common Stock (6,775 units at $2.63), decreasing ownership by 4% to 144,757 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1937d
  SEC Form 4: P Pamela Palmer disposed of $23,446 worth of Common Stock (8,915 units at $2.63), decreasing ownership by 1% to 593,098 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1937d
  SEC Form 4: J. Vincent Angotti disposed of $60,627 worth of Common Stock (23,052 units at $2.63), decreasing ownership by 5% to 427,887 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1940d
  SEC Form 4: Raffi Asadorian disposed of $24,382 worth of Common Stock (9,414 units at $2.59), decreasing ownership by 5% to 192,323 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1940d
  SEC Form 4: N Badri Dasu disposed of $17,731 worth of Common Stock (6,846 units at $2.59), decreasing ownership by 4% to 151,532 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1940d
  SEC Form 4: P Pamela Palmer disposed of $24,382 worth of Common Stock (9,414 units at $2.59), decreasing ownership by 2% to 602,013 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)
• 1940d
  SEC Form 4: J. Vincent Angotti disposed of $64,903 worth of Common Stock (25,059 units at $2.59), decreasing ownership by 5% to 450,939 units

  4 - ACELRX PHARMACEUTICALS INC (0001427925) (Issuer)

Other ACRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends